BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 16978209)

  • 1. Immunohistochemical detection of protein kinase C-beta (PKC-beta) in tumour specimens of patients with non-small cell lung cancer.
    Lahn M; McClelland P; Ballard D; Mintze K; Thornton D; Sandusky G
    Histopathology; 2006 Oct; 49(4):429-31. PubMed ID: 16978209
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunohistochemical detection of nuclear survivin in NSCLC: a comparison of commercial antibodies.
    Vischioni B; Oudejans JJ; Kruyt FA; Giaccone G; Rodriguez JA
    Histopathology; 2007 Apr; 50(5):671-5. PubMed ID: 17394508
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
    Zech VF; Dlaska M; Tzankov A; Hilbe W
    Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin A and Cyclin E expression in resected non-small cell lung cancer stage I-IIIA.
    Kosacka M; Piesiak P; Porebska I; Korzeniewska A; Dyla T; Jankowska R
    In Vivo; 2009; 23(4):519-25. PubMed ID: 19567385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH; Cho JY; Moon JT; Kim HJ; Kim SK; Shin DH; Chang J; Ahn CM; Kim SK; Chang YS
    Oncol Rep; 2006 Dec; 16(6):1205-10. PubMed ID: 17089038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
    Na IK; Scheibenbogen C; Adam C; Stroux A; Ghadjar P; Thiel E; Keilholz U; Coupland SE
    Hum Pathol; 2008 Dec; 39(12):1751-5. PubMed ID: 18701133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer.
    Soltermann A; Tischler V; Arbogast S; Braun J; Probst-Hensch N; Weder W; Moch H; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(22):7430-7. PubMed ID: 19010860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
    Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
    In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of hnRNPA2/B1 in bronchoscopic specimens: a potential early detection marker in lung cancer.
    Katsimpoula S; Patrinou-Georgoula M; Makrilia N; Dimakou K; Guialis A; Orfanidou D; Syrigos KN
    Anticancer Res; 2009 Apr; 29(4):1373-82. PubMed ID: 19414390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective expression of transforming growth factor beta type II receptor (TGFBR2) in the large cell variant of non-small cell lung carcinoma.
    Xu JB; Bao Y; Liu X; Liu Y; Huang S; Wang JC
    Lung Cancer; 2007 Oct; 58(1):36-43. PubMed ID: 17566598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
    Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cathepsin B expression and its significance in non-small cell lung cancer tissues].
    Yang HZ; Zhang WD; Yang HP; Hu C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):729-30. PubMed ID: 16708822
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
    Apostolopoulou K; Pateras IS; Evangelou K; Tsantoulis PK; Liontos M; Kittas C; Tiniakos DG; Kotsinas A; Cordon-Cardo C; Gorgoulis VG
    J Pathol; 2007 Nov; 213(3):294-302. PubMed ID: 17907153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer.
    Volante M; Saviozzi S; Rapa I; Ceppi P; Cappia S; Calogero R; Novello S; Borasio P; Papotti M; Scagliotti GV
    Cancer; 2007 Sep; 110(6):1321-8. PubMed ID: 17647268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer.
    Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
    Timotheadou E; Skarlos DV; Samantas E; Papadopoulos S; Murray S; Skrickova J; Christodoulou C; Papakostantinou C; Pectasides D; Papakostas P; Kaplanova J; Vrettou E; Karina M; Kosmidis P; Fountzilas G
    Anticancer Res; 2007; 27(6C):4481-9. PubMed ID: 18214064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different impact of excision repair cross-complementing group 1 on survival.
    Panasci LC
    J Clin Oncol; 2010 Apr; 28(10):e163; author reply e164. PubMed ID: 20159805
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of transcription factor Pokemon in non-small cell lung cancer and its clinical significance.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Fu K; Zhang J
    Chin Med J (Engl); 2008 Mar; 121(5):445-9. PubMed ID: 18364119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.